{"filings":[{"id":1473556,"accession_number":"0001493152-26-032191","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2026-07-06T20:59:38+00:00","items":["1.01","5.01","5.02","9.01"],"status":"ready","headline":"Trafalgar Asset Management acquires voting control of Greater Cannabis Company, appoints new CEO","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Trafalgar Asset Management purchased 100% of Series A and Series B preferred stock, gaining 96.62% voting power as of June 29, 2026.","Porfirio Sanchez Talavera appointed CEO and Chairman; Aitan Zacharin resigned as officer and will leave board after 10-day Rule 14f-1 period.","Certain company indebtedness was compromised, settled, and extinguished via Debt Cancellation and Release Agreements with creditors.","Transactions consummated under an Escrow Agreement with John D. Thomas, P.C. as escrow agent; exhibits filed with the 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123737,"accession_number":"0001493152-25-019751","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2025-10-27T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"GCAN files Series B Preferred Stock giving CEO Aitan Zacharin 51% voting control","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Created 1,000 Series B Convertible Preferred Shares with 51% total voting power.","Issued to CEO Aitan Zacharin in exchange for waiving $20,000 in accrued unpaid compensation.","Each Series B share converts into 100,000 common shares, subject to anti-dilution adjustments.","Series B has no dividend rights; liquidation preference of $0.001 per share.","Super-voting rights terminate if converted or transferred to a third party."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123735,"accession_number":"0001493152-25-018271","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K/A","filed_at":"2025-10-16T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Greater Cannabis delays reverse stock split effective date; 1:1500 split effective Oct 16, trading Oct 17","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["1-for-1500 reverse split effective after close Oct 16, 2025; trading on post-split basis starts Oct 17.","Shares outstanding reduced from 1,349,888,436 to approximately 900,256; no fractional shares issued.","Ticker symbol will be GCAND for 20 trading days starting Oct 17; new CUSIP 391657202.","Amendment filed due to administrative oversight delaying FINRA listing; original effective date was Oct 15.","Authorized shares unchanged at unspecified amount; par value remains $0.001 per share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123736,"accession_number":"0001493152-25-018088","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2025-10-15T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Greater Cannabis implements 1-for-1,500 reverse stock split effective Oct 15, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Outstanding shares reduced from 1,349,888,436 to approximately 900,256.","Ticker symbol changes to GCAND for 20 trading days starting Oct 16, 2025.","No fractional shares issued; holders of fractional shares receive one whole share.","Authorized shares and par value ($0.001) remain unchanged; convertible securities also split."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158084,"accession_number":"0001641172-25-003602","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2025-04-10T23:59:59+00:00","items":["3.02","5.02"],"status":"ready","headline":"GCAN issues 100M shares to CEO for $10K deferred salary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Aitan Zacharin received 100,000,000 restricted shares on April 3, 2025.","Shares cover $10,000 in deferred compensation, implying $0.0001 per share.","Issued under Section 4(a)(2) exemption from Securities Act registration.","Issuance significantly dilutes existing shareholders without additional capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176466,"accession_number":"0001493152-25-009379","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2025-03-06T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Greater Cannabis replaces auditor; prior audit includes going concern doubt","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board terminated Olayinka Oyebola & Co. on March 6, 2025; engaged Aloba Awomolo & Partners same day.","No disagreements or reportable events occurred with former auditor; unanimous board approval March 5.","Olayinka's 2023 audit report included explanatory paragraph on substantial doubt about going concern.","Company did not consult new auditor on accounting principles or disagreements prior to engagement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281237,"accession_number":"0001493152-23-029102","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2023-08-16T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Greater Cannabis Co. increases Series A Preferred voting power to 1.76 votes per share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Effective June 13, 2023, amended Articles to increase Series A Preferred voting power to 1.76 votes per share.","Amendment to Articles of Incorporation filed as Exhibit 3.1.","Company is The Greater Cannabis Company Inc. (GCAN), a Florida corporation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320096,"accession_number":"0001493152-23-002551","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2023-01-26T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"GCAN replaces independent auditor Fruci with Olayinka Oyebola & Co effective Jan 25, 2023","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Ended engagement of Fruci & Associates II, PLLC as independent auditor on January 25, 2023, approved by board.","No disagreements or reportable events with former auditor during fiscal 2021 and subsequent period.","Prior Fruci reports contained a going-concern explanatory paragraph but no adverse or qualified opinion.","Engaged Olayinka Oyebola & Co as new independent registered public accounting firm effective same date.","No prior consultations with new auditor regarding accounting principles, transactions, or audit opinions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":373851,"accession_number":"0001493152-22-017277","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2022-06-21T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"GCAN amends convertible note conversion price to $0.001 for up to $100k","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Conversion price set at $0.001 per share for up to $100,000 in principal and interest under a $272,500 note.","Amendment effective May 27, 2022; filed June 19, 2022.","Note originally issued June 28, 2021 to FirstFire Global Opportunities Fund LLC.","Amends Securities Purchase Agreement dated March 11, 2021, as previously amended."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":373850,"accession_number":"0001493152-22-014426","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2022-05-19T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"GCAN extends note maturities to April 2023, obtains default waiver from FFG","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Extended maturity of two Convertible Promissory Notes (each $272,500 principal) to April 30, 2023.","FFG waived all Events of Default as of May 1, 2022 under the Notes and related Transaction Documents.","Notes originally issued March 11, 2021 and June 28, 2021 under Amended Securities Purchase Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410858,"accession_number":"0001493152-21-027705","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K/A","filed_at":"2021-11-10T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"GCAN replaces auditor from Studer to Fruci effective August 1, 2021","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Engagement of Michael T. Studer CPA P.C. ended August 1, 2021; no disagreements or reportable events reported.","Fruci & Associates II, PLLC appointed as new independent registered public accounting firm effective same date.","Prior auditor's reports for FY 2019 and FY 2020 included a going-concern explanatory paragraph.","Board of directors unanimously approved both the dismissal and the new engagement on August 1, 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410859,"accession_number":"0001493152-21-026807","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2021-11-01T23:59:59+00:00","items":["1.02","5.02"],"status":"ready","headline":"Greater Cannabis general counsel Mark Radom resigns; service agreement terminated","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mark Radom resigned as general counsel effective October 25, 2021, to pursue other opportunities.","Company and Radom mutually agreed to terminate his service agreement.","No replacement has been named for the general counsel position."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":429627,"accession_number":"0001493152-21-020666","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2021-08-19T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"GCAN signs licensing/research deal with Shaare Zedek for cannabinoid therapy targeting neuropsychiatric disorders","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Licensing covers novel cannabinoid therapeutic for autism, schizophrenia, Parkinson's, Alzheimer's, and other neuropsychiatric disorders.","Joint R&D agreement with Shaare Zedek Scientific, technology transfer arm of Jerusalem's Shaare Zedek Medical Center.","Dr. Adi Aran, SZMC pediatric neurology director and cannabis research pioneer, will lead continued clinical program.","Director David Tavor resigned effective August 19, 2021.","No financial terms of the agreements were disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":429626,"accession_number":"0001493152-21-018526","cik":1695473,"company_name":"Greater Cannabis Company, Inc.","ticker":"GCAN","form_type":"8-K","filed_at":"2021-08-04T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Greater Cannabis Company dismisses auditor Studer, appoints Fruci & Associates","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Dismissed Michael T. Studer CPA P.C. as independent auditor effective August 1, 2021; no disagreements or reportable events.","Engaged Fruci & Associates, PS as new independent registered public accounting firm, effective same date.","Prior Studer reports for 2019 and 2020 contained going concern explanatory paragraph but no adverse opinion.","Board unanimously approved both changes on August 1, 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":137016.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}